Newsroom
DOJ Introduces Safe-Harbor Policy for Disclosing Uncovered Misconduct During Mergers and Acquisitions
If Your Organization May Acquire or Be Acquired by Another Corporate Entity, Be Mindful of the Critical Importance of Corporate Compliance On October 4, 2023, the Department of Justice (“DOJ”), through Deputy Attorney General Lisa Monaco, announced a new safe-harbor policy for voluntary disclosures of corporate misconduct uncovered in connection…
MedPro Systems Appoints Former Federal Prosecutor & Chief at the U.S. Attorney’s Office Maureen Ruane as Director, Compliance Advisory Services
Strengthening MedPro’s In-House Compliance Expertise for Building, Maintaining and Enhancing Effective Compliance Programs for the Life Sciences Industry That Can Best Withstand and Potentially Avoid Government Scrutiny View the official press release here. MOUNT ARLINGTON, N.J., Sept. 19, 2023 — MedPro Systems, the leading provider of commercial and compliance solutions…
2023 Transparency and Aggregate Spend Conference Insights
The MedPro Systems team recently enjoyed attending Informa’s 2023 Transparency, Aggregate Spend & HCP Engagement conference in Washington, D.C. It was an excellent opportunity to connect with so many Life Sciences organizations, teams, and people we support, while keeping current on the newest challenges facing our industry. Access MedPro’s Presentations…
Webinar: Your Passport to Global Transparency Reporting
The webinar has ended but you may request a complimentary copy of the full recording – here Looking to launch a new or existing product cross-jurisdictions, countries or even continents? It’s best to have a compliance itinerary! In this webinar, MedPro’s Compliance Advisory Services team breaks down everything you need…
MedPro Systems Launches State Drug Price Reporting Reference Solution
MOUNT ARLINGTON, N.J., Jan. 31, 2023 — MedPro Systems, the leading provider of commercial and compliance solutions for the Life Sciences industry, today launched an expansion to their authoritative transparency reference library solution, RegulatoryID, to cover US state drug price reporting regulations. With this expansion, pharmaceutical manufacturers can view and…
Webinar: Navigate State Drug Price Reporting with Ease
From launching a new product to adjusting existing price structures, it’s critical that pharmaceutical manufacturers are aware of how their pricing decisions can trigger state-level reporting obligations across the US. However, with more than 30 unique reporting requirements already enacted and more pending legislation on the way, it can be…